All Stories

  1. Uncertainty-Aware Multiscale Treatment Response Forecasting in Advanced Non-Small Cell Lung Cancer Using Residual-Variance Conformal Prediction
  2. The Next Frontier in Quantitative Co-Clinical Imaging to Advance Functional Precision Oncology
  3. Data from Mature Outcomes and Patterns of Failure in the Phase II FLARE-RT Trial of Biological Image-Guided and Risk-Adaptive Chemoradiation for Unresectable NSCLC
  4. Supplementary Figure S1 from Mature Outcomes and Patterns of Failure in the Phase II FLARE-RT Trial of Biological Image-Guided and Risk-Adaptive Chemoradiation for Unresectable NSCLC
  5. Supplementary Figure S2 from Mature Outcomes and Patterns of Failure in the Phase II FLARE-RT Trial of Biological Image-Guided and Risk-Adaptive Chemoradiation for Unresectable NSCLC
  6. Supplementary Figure S3 from Mature Outcomes and Patterns of Failure in the Phase II FLARE-RT Trial of Biological Image-Guided and Risk-Adaptive Chemoradiation for Unresectable NSCLC
  7. Supplementary Figure S4 from Mature Outcomes and Patterns of Failure in the Phase II FLARE-RT Trial of Biological Image-Guided and Risk-Adaptive Chemoradiation for Unresectable NSCLC
  8. Supplementary Table S1 from Mature Outcomes and Patterns of Failure in the Phase II FLARE-RT Trial of Biological Image-Guided and Risk-Adaptive Chemoradiation for Unresectable NSCLC
  9. Supplementary Table S2 from Mature Outcomes and Patterns of Failure in the Phase II FLARE-RT Trial of Biological Image-Guided and Risk-Adaptive Chemoradiation for Unresectable NSCLC
  10. Supplementary Table S3 from Mature Outcomes and Patterns of Failure in the Phase II FLARE-RT Trial of Biological Image-Guided and Risk-Adaptive Chemoradiation for Unresectable NSCLC
  11. Supplementary Table S4 from Mature Outcomes and Patterns of Failure in the Phase II FLARE-RT Trial of Biological Image-Guided and Risk-Adaptive Chemoradiation for Unresectable NSCLC
  12. Supplementary Table S5 from Mature Outcomes and Patterns of Failure in the Phase II FLARE-RT Trial of Biological Image-Guided and Risk-Adaptive Chemoradiation for Unresectable NSCLC
  13. Supplementary Table S6 from Mature Outcomes and Patterns of Failure in the Phase II FLARE-RT Trial of Biological Image-Guided and Risk-Adaptive Chemoradiation for Unresectable NSCLC
  14. Supplementary Table S7 from Mature Outcomes and Patterns of Failure in the Phase II FLARE-RT Trial of Biological Image-Guided and Risk-Adaptive Chemoradiation for Unresectable NSCLC
  15. An integrated PET/CT simulation framework for virtual imaging trials and quantitative performance evaluation
  16. Mature Outcomes and Patterns of Failure in the Phase II FLARE-RT Trial of Biological Image-guided and Risk-Adaptive Chemoradiation for Unresectable NSCLC
  17. Scale-aware adaptive supervised network with limited medical annotations
  18. VisionUnite: A Vision-Language Foundation Model for Ophthalmology Enhanced With Clinical Knowledge
  19. Tumor Size Is Not Everything: Advancing Radiomics as a Precision Medicine Biomarker in Oncology Drug Development and Clinical Care. A Report of a Multidisciplinary Workshop Coordinated by the RECIST Working Group
  20. The emergence of PET/CT: Engineering, innovation, and usage
  21. Regularizing the Deepsurv Network Using Projection Loss for Medical Risk Assessment
  22. Timing, energy, and 3D spatial resolution of the BING PET detector module
  23. Synthetic PET via Domain Translation of 3D MRI
  24. Evaluation of attenuation correction in PET/MRI with synthetic lesion insertion
  25. Standards, Phantoms, and Site Qualification
  26. Impact of Using Uniform Attenuation Coefficients for Heterogeneously Dense Breasts in a Dedicated Breast PET/X-Ray Scanner
  27. Virtual Clinical Trials: Why and What (Special Section Guest Editorial)
  28. Virtual clinical trials in medical imaging: a review
  29. Deep learning-based model observers that replicate human observers for PET imaging
  30. The QIBA Profile for FDG PET/CT as an Imaging Biomarker Measuring Response to Cancer Therapy
  31. PET/CT-guided biopsy with respiratory motion correction
  32. Task Group 174 Report: Utilization of [ 18 F]Fluorodeoxyglucose Positron Emission Tomography ([ 18 F]FDG‐PET) in Radiation Therapy
  33. Improved model prediction of glioma growth utilizing tissue-specific boundary effects
  34. Performance evaluation of the 5‐Ring GE Discovery MI PET/CT system using the national electrical manufacturers association NU 2‐2012 Standard
  35. Voxel Forecast for Precision Oncology: Predicting Spatially Variant and Multiscale Cancer Therapy Response on Longitudinal Quantitative Molecular Imaging
  36. Comparison of prediction models with radiological semantic features and radiomics in lung cancer diagnosis of the pulmonary nodules: a case-control study
  37. Tumor-derived Autoantibodies Identify Malignant Pulmonary Nodules
  38. Erratum: Measuring temporal stability of positron emission tomography standardized uptake value bias using long-lived sources in a multicenter network
  39. The Impact of Arterial Input Function Determination Variations on Prostate Dynamic Contrast-Enhanced Magnetic Resonance Imaging Pharmacokinetic Modeling: A Multicenter Data Analysis Challenge, Part II
  40. Bias in PET Images of Solid Phantoms Due to CT-Based Attenuation Correction
  41. Special Section Guest Editorial: Artificial Intelligence in Medical Imaging
  42. The Use of Quantitative Imaging in Radiation Oncology: A Quantitative Imaging Network (QIN) Perspective
  43. Test–Retest Reproducibility of 18F-FDG PET/CT Uptake in Cancer Patients Within a Qualified and Calibrated Local Network
  44. The PET/X dedicated breast-PET scanner for optimizing cancer therapy
  45. Multisite Concordance of DSC-MRI Analysis for Brain Tumors: Results of a National Cancer Institute Quantitative Imaging Network Collaborative Project
  46. Prospective Study of Serial 18F-FDG PET and 18F-Fluoride PET to Predict Time to Skeletal-Related Events, Time to Progression, and Survival in Patients with Bone-Dominant Metastatic Breast Cancer
  47. Simulating magnetic resonance images based on a model of tumor growth incorporating microenvironment
  48. Deep-learning derived features for lung nodule classification with limited datasets
  49. Multicenter survey of PET/CT protocol parameters that affect standardized uptake values
  50. Impact of tumour motion compensation and delineation methods on FDG PET-based dose painting plan quality for NSCLC radiation therapy
  51. Simulation study of quantitative precision of the PET/X dedicated breast PET scanner
  52. Tumor radiomic heterogeneity: Multiparametric functional imaging to characterize variability and predict response following cervical cancer radiation therapy
  53. Multisite concordance of apparent diffusion coefficient measurements across the NCI Quantitative Imaging Network
  54. Demonstration of PET System Design Trade-offs Using Small Lesion Detectability as a Metric and Measured Phantom Data
  55. Impact of Patient Size on Image Quality in Clinical PET with a Convergent Penalized-Likelihood Image Reconstruction Algorithm
  56. Functional lung avoidance and response-adaptive escalation (FLARE) RT: Multimodality plan dosimetry of a precision radiation oncology strategy
  57. A virtual clinical trial comparing static versus dynamic PET imaging in measuring response to breast cancer therapy
  58. Special Section Guest Editorial: Positron Emission Tomography: History, Current Status, and Future Prospects
  59. A phantom design and assessment of lesion detectability in PET imaging
  60. Improved attenuation correction for respiratory gated PET/CT with extended-duration cine CT: a simulation study
  61. Statistical distributions of ultra-low dose CT sinograms and their fundamental limits
  62. Framework for radiation pneumonitis risk stratification based on anatomic and perfused lung dosimetry
  63. Qualification of National Cancer Institute–Designated Cancer Centers for Quantitative PET/CT Imaging in Clinical Trials
  64. Comparison Between Pre-Log and Post-Log Statistical Models in Ultra-Low-Dose CT Reconstruction
  65. Multi-site quality and variability analysis of 3D FDG PET segmentations based on phantom and clinical image data
  66. Performance Observations of Scanner Qualification of NCI-Designated Cancer Centers: Results From the Centers of Quantitative Imaging Excellence (CQIE) Program
  67. Direct Reconstruction of CT-based Attenuation Correction Images for PET with Cluster-Based Penalties
  68. Evaluation of lesion detectability in positron emission tomography when using a convergent penalized likelihood image reconstruction method
  69. Evaluation of event position reconstruction in monolithic crystals that are optically coupled
  70. Fast analytical approach of application specific dose efficient spectrum selection for diagnostic CT imaging and PET attenuation correction
  71. Mixed Confidence Estimation for Iterative CT Reconstruction
  72. A phantom design for assessment of detectability in PET imaging
  73. Brown Adipose Reporting Criteria in Imaging STudies (BARCIST 1.0): Recommendations for Standardized FDG-PET/CT Experiments in Humans
  74. Measuring total liver function on sulfur colloid SPECT/CT for improved risk stratification and outcome prediction of hepatocellular carcinoma patients
  75. Characterization of PET/CT images using texture analysis: the past, the present… any future?
  76. Designing a compact high performance brain PET scanner—simulation study
  77. Statistical Issues in Testing Conformance with the Quantitative Imaging Biomarker Alliance (QIBA) Profile Claims
  78. Radiomics: Images Are More than Pictures, They Are Data
  79. Quantitative Imaging in Cancer Clinical Trials
  80. An algorithm for automated ROI definition in water or epoxy-filled NEMA NU-2 image quality phantoms
  81. Positron Emission Tomography: Current Challenges and Opportunities for Technological Advances in Clinical and Preclinical Imaging Systems
  82. Cherenkov luminescence measurements with digital silicon photomultipliers: a feasibility study
  83. Addendum to ‘A patient-specific computational model of hypoxia-modulated radiation resistance in glioblastoma using18F-FMISO-PET’
  84. A Digital Reference Object to Analyze Calculation Accuracy of PET Standardized Uptake Value
  85. Multicenter Clinical Trials Using 18F-FDG PET to Measure Early Response to Oncologic Therapy: Effects of Injection-to-Acquisition Time Variability on Required Sample Size
  86. A phantom design for assessment of detectability using a lumpy background and 3D-printed features
  87. An improved statistical approach to the estimation of spatial bias and variability in reconstructed PET data
  88. Simulation study for designing a compact brain PET scanner
  89. Ultra-low dose CT attenuation correction for PET/CT: analysis of sparse view data acquisition and reconstruction algorithms
  90. AAPM/SNMMI Joint Task Force: report on the current state of nuclear medicine physics training
  91. Quantitative radiomics: impact of stochastic effects on textural feature analysis implies the need for standards
  92. In silico analysis suggests differential response to bevacizumab and radiation combination therapy in newly diagnosed glioblastoma
  93. The Value of Establishing the Quantitative Accuracy of PET/CT Imaging
  94. Comparison of prone versus supine 18F-FDG-PET of locally advanced breast cancer: Phantom and preliminary clinical studies
  95. Performance assessment of a NaI(Tl) gamma counter for PET applications with methods for improved quantitative accuracy and greater standardization
  96. Differential hepatic avoidance radiation therapy: Proof of concept in hepatocellular carcinoma patients
  97. Imaging and dosimetric errors in 4D PET/CT-guided radiotherapy from patient-specific respiratory patterns: a dynamic motion phantom end-to-end study
  98. Summary of the UPICT Protocol for 18F-FDG PET/CT Imaging in Oncology Clinical Trials
  99. Improving lesion detectability in PET imaging with a penalized likelihood reconstruction algorithm
  100. A patient-specific computational model of hypoxia-modulated radiation resistance in glioblastoma using 18F-FMISO-PET
  101. Impact of CT attenuation correction method on quantitative respiratory-correlated (4D) PET/CT imaging
  102. Analysis of statistical models for iterative reconstruction of extremely low-dose CT data
  103. Comparison between pre-log and post-log statistical models in low-dose CT iterative reconstruction
  104. Improving lesion detectability in low uptake 18 F-FDG breast cancer by optimizing PET imaging time
  105. Spatial covariance characteristics in a collection of 3-D PET scanners used in clinical imaging trials
  106. Statistical comparison of likelihood models for low dose x-ray CT
  107. Multimodality molecular imaging of the lung
  108. An OpenPET scanner with bridged detectors to compensate for incomplete data
  109. Assessment of patient selection criteria for quantitative imaging with respiratory-gated positron emission tomography
  110. Multiplexing strategies for monolithic crystal PET detector modules
  111. Letter to Cancer Center Directors: Progress in Quantitative Imaging As a Means to Predict and/or Measure Tumor Response in Cancer Therapy Trials
  112. Quantitative imaging biomarkers: A review of statistical methods for computer algorithm comparisons
  113. Meta-analysis of the technical performance of an imaging procedure: Guidelines and statistical methodology
  114. X-ray pulsing methods for reduced-dose computed tomography in PET/CT attenuation correction
  115. Respiratory trace feature analysis for the prediction of respiratory-gated PET quantification
  116. Errors in Quantitative Image Analysis due to Platform-Dependent Image Scaling
  117. Variations of Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Evaluation of Breast Cancer Therapy Response: A Multicenter Data Analysis Challenge
  118. A Virtual Clinical Trial of FDG-PET Imaging of Breast Cancer: Effect of Variability on Response Assessment
  119. Biases in Multicenter Longitudinal PET Standardized Uptake Value Measurements
  120. Quantitative Imaging Network: Data Sharing and Competitive AlgorithmValidation Leveraging The Cancer Imaging Archive
  121. Dual energy CT for attenuation correction with PET/CT
  122. Multicenter trials using 18F-fluorodeoxyglucose (FDG) PET to predict chemotherapy response: Effects of differential measurement error and bias on power calculations for unselected and enrichment designs
  123. A digital reference object for the 3D Hoffman brain phantom for characterization of PET neuroimaging quality
  124. Analysis of optimal CT spectrum for PET attenuation correction
  125. Direct reconstruction of CT-based attenuation correction images for PET with cluster-based penalties
  126. Effects of Detector Thickness on Geometric Sensitivity and Event Positioning Errors in the Rectangular PET/X Scanner
  127. Experimental evaluation of a deformable registration algorithm for motion correction in PET-CT guided biopsy
  128. Image reconstruction in rectangular PET systems using distance-driven projections
  129. Evaluation of strategies towards harmonization of FDG PET/CT studies in multicentre trials: comparison of scanner validation phantoms and data analysis procedures
  130. Overview and a Word of Thanks
  131. SU-C-141-04: Robustness of 4DCT and 4DCBCT Object Volume Measurement with a Motion-Capable Lung Phantom That Mimics Realistic Patient Tumor Trajectories
  132. SU-D-141-06: Patient-Specific Imaging and Dosimetric Errors in PET/CT-Guided Radiotherapy of Lung Cancer
  133. TU-A-141-01: Multi Modal PET/CT Imaging for Therapy Response Early Prediction and Therapy Monitoring
  134. TU-E-141-09: Impact of Attenuation Correction Mode On 4D PET/CT for Target Definition in Lung Cancer Patients
  135. Model-Based Iterative Reconstruction Versus Adaptive Statistical Iterative Reconstruction and Filtered Back Projection in Liver 64-MDCT: Focal Lesion Detection, Lesion Conspicuity, and Image Noise
  136. Quantitative assessment of dynamic PET imaging data in cancer imaging
  137. Early experiences in establishing a regional quantitative imaging network for PET/CT clinical trials
  138. Enhancing clinical utility of respiratory-gated PET/CT using patient respiratory trace classification
  139. Detector position estimation for PET scanners
  140. MO-A-BRA-01: State of the Art in Quantitative Imaging in CT, PET and MRI
  141. TU-C-217BCD-01: Where Molecular Imaging Is Taking Us
  142. Accuracy of CT-based attenuation correction in PET/CT bone imaging
  143. Recommendations for measurement of tumour vascularity with positron emission tomography in early phase clinical trials
  144. Design Considerations for using PET as a Response Measure in Single Site and Multicenter Clinical Trials
  145. Introduction and a Word of Thanks
  146. Ultra-low dose CT attenuation correction for PET/CT
  147. Dual-radioisotope PET data acquisition and analysis
  148. Resolution Properties of a Prototype Continuous Miniature Crystal Element (cMiCE) Scanner
  149. Properties and Mitigation of Edge Artifacts in PSF-Based PET Reconstruction
  150. Effective count rates for PET scanners with reduced and extended axial field of view
  151. Applying a patient-specific bio-mathematical model of glioma growth to develop virtual [18F]-FMISO-PET images
  152. A robust state-space kinetics-guided framework for dynamic PET image reconstruction
  153. Quantifying and Reducing the Effect of Calibration Error on Variability of PET/CT Standardized Uptake Value Measurements
  154. Respiratory motion correction for quantitative PET/CT using all detected events with internal—external motion correlation
  155. Effects of MR surface coils on PET quantification
  156. DOI-based reconstruction algorithms for a compact breast PET scanner
  157. Positron Emission Tomography-Computed Tomography Standardized Uptake Values in Clinical Practice and Assessing Response to Therapy
  158. Multimodality molecular imaging of the lung
  159. Resolution properties of a prototype continuous miniature crystal element (cMiCE) scanner
  160. Properties of edge artifacts in PSF-based PET reconstruction
  161. Image reconstruction for PET/CT scanners: past achievements and future challenges
  162. SU-GG-J-142: Investigation of MIP PET in Motion-Encompassing Methods to Account for Respiratory Motion in Radiotherapy
  163. TU-C-201C-02: Physical Validation of PET/CT for Imaging as a Biomarker
  164. Advancements to the planogram frequency–distance rebinning algorithm
  165. Noise and bias properties of monoenergetic images from DECT used for attenuation correction with PET/CT and SPECT/CT
  166. Application and Evaluation of a Measured Spatially Variant System Model for PET Image Reconstruction
  167. Noise and signal properties in PSF-based fully 3D PET image reconstruction: an experimental evaluation
  168. Variability in PET quantitation within a multicenter consortium
  169. Quiescent period respiratory gating for PET/CT
  170. Instrumentation factors affecting variance and bias of quantifying tracer uptake with PET/CT
  171. Attenuation-emission alignment in cardiac PET/CT based on consistency conditions
  172. Quantitative Imaging to Assess Tumor Response to Therapy: Common Themes of Measurement, Truth Data, and Error Sources
  173. PET/CT Assessment of Response to Therapy: Tumor Change Measurement, Truth Data and Error
  174. The impact of respiratory motion on tumor quantification and delineation in static PET/CT imaging
  175. Statistical Sinogram Restoration in Dual-Energy CT for PET Attenuation Correction
  176. Statistical LOR estimation for a high-resolution dMiCE PET detector
  177. Limits of ultra-low dose CT attenuation correction for PET/CT
  178. Impact on Image Noise of Incorporating Detector Blurring Into Image Reconstruction for a Small Animal PET Scanner
  179. Fast kVp-switching dual energy CT for PET attenuation correction
  180. Evaluation of noise properties in PSF-based PET image reconstruction
  181. Determining block detector positions for PET scanners
  182. Weight-Based, Low-Dose Pediatric Whole-Body PET/CT Protocols
  183. Clinical Imaging Characteristics of the Positron Emission Mammography Camera: PEM Flex Solo II
  184. Statistical three-dimensional positioning algorithm for high-resolution dMiCE PET detector
  185. Clinical imaging characteristics of the positron emission mammography PEM Flex Solo II
  186. The Reference Image Database to Evaluate Response to Therapy in Lung Cancer (RIDER) Project: A Resource for the Development of Change-Analysis Software
  187. Planogram Rebinning With the Frequency-Distance Relationship
  188. Measured count-rate performance of the Discovery STE PET/CT scanner in 2D, 3D and partial collimation acquisition modes
  189. Image Reconstruction for a Partially Collimated Whole Body PET Scanner
  190. Application of a spatially variant system model for 3-D whole-body pet image reconstruction
  191. Low-dose dual-energy computed tomography for PET attenuation correction with statistical sinogram restoration
  192. Gas Bubble Motion Artifact in MDCT
  193. The positron emission mammography/tomography breast imaging and biopsy system (PEM/PET): design, construction and phantom-based measurements
  194. Quantification of radiotracer uptake with a dedicated breast PET imaging system
  195. Statistical image reconstruction from correlated data with applications to PET
  196. Effect of Reconstruction Algorithms on Myocardial Blood Flow Measurement with 13N-Ammonia PET
  197. Optimization of Noise Equivalent Count Rate Performance for a Partially Collimated PET Scanner by Varying the Number of Septa
  198. Dynamic and Static Approaches to Quantifying 18F-FDG Uptake for Measuring Cancer Response to Therapy, Including the Effect of Granulocyte CSF
  199. Cine CT for Attenuation Correction in Cardiac PET/CT
  200. Evaluation of Multiclass Model Observers in PET LROC Studies
  201. Reproducibility of quantifying tracer uptake with PET/CT for evaluation of response to therapy
  202. Expanding SimSET to include block detectors: performance with pseudo-blocks and a true block model
  203. Estimating live-time for new PET scanner configurations
  204. Consistency driven respiratory phase alignment and motion compensation in PET/CT
  205. Accuracy of CT-Based attenuation correction in bone imaging with PET/CT
  206. A generalized simulation description language
  207. Automatic arm removal in PET and CT images for deformable registration
  208. Dual Energy CT Attenuation Correction Methods for Quantitative Assessment of Response to Cancer Therapy with PET/CT Imaging
  209. Modeling and incorporation of system response functions in 3-D whole body PET
  210. Numerical observer studies comparing FORE+AWOSEM, FORE+NECOSEM and NEC based fully 3-D OSEM for 3-D whole-body PET imaging
  211. [11C]Metahydroxyephedrine and [18F]Fluorodeoxyglucose Positron Emission Tomography Improve Clinical Decision Making in Suspected Pheochromocytoma
  212. Simulations of the Effect of Collimation on Count Rates of an LSO PET System
  213. Improved PET Detection of Focal Brain Activity Using Subset-dependent Relaxation `Dynamic' Row-action Maximum Likelihood Algorithm (DRAMA)
  214. Count-Rate Performance of the Discovery STE PET Scanner Using Partial Collimation
  215. Tumor delineation using PET in head and neck cancers: Threshold contouring and lesion volumes
  216. Improved quantitation for PET/CT image reconstruction with system modeling and anatomical priors
  217. Attenuation-Emission Alignment in Cardiac PET/CT with Consistency Conditions
  218. Analytical reconstruction of deconvolved Fourier rebinned PET sinograms
  219. SU-FF-J-106: FMISO-PET Hypoxia Imaging: A Novel Method to Plan IMRT-Based Boost Radiation to Hypoxic Subvolumes
  220. SU-FF-J-107: Tumor-Delineation Uncertainties in FDG-PET and FMISO-PET Images and the Effect On Radiation Therapy Plans
  221. Improved quantitation for PET/CT image reconstruction with system modeling and anatomical priors
  222. Simulation of countrate performance for a PET scanner with partial collimation
  223. Effect of patient thickness and scan duration on lesion detectability in PET oncology imaging
  224. Advanced PET/CT fusion workstation for oncology imaging
  225. FDG-PET/CT-guided intensity modulated head and neck radiotherapy: A pilot investigation
  226. FDG-PET/CT imaging for preradiotherapy staging of head-and-neck squamous cell carcinoma
  227. PET/CT scanner instrumentation, challenges, and solutions
  228. PET instrumentation
  229. Distribution of 1-(2-Deoxy-2-fluoro- -D-arabinofuranosyl) Uracil in Mice Bearing Colorectal Cancer Xenografts: Rationale for Therapeutic Use and as a Positron Emission Tomography Probe for Thymidylate Synthase
  230. Pragmatic fully 3D image reconstruction for the MiCES mouse imaging PET scanner
  231. Volumetric model and human observer comparisons of tumor detection for whole-body positron emission tomography1
  232. Fast Fully 3-D Image Reconstruction in PET Using Planograms
  233. Impact of System Design Parameters on Image Figures of Merit for a Mouse PET Scanner
  234. A Comparison of Planar Versus Volumetric Numerical Observers for Detection Task Performance in Whole-Body PET Imaging
  235. Analytic Image Reconstruction Methods
  236. Fast PET EM Reconstruction From Linograms
  237. X-ray-based attenuation correction for positron emission tomography/computed tomography scanners
  238. Weight Loss-Induced Plasticity of Glucose Transport and Phosphorylation in the Insulin Resistance of Obesity and Type 2 Diabetes
  239. Performance comparisons of planar and volumetric observers for lesion detection in PET scanning
  240. Postinjection single photon transmission tomography with ordered-subset algorithms for whole-body PET imaging
  241. Clinically feasible reconstruction of 3D whole-body PET/CT data using blurred anatomical labels
  242. Comparison of 3-D reconstruction with 3D-OSEM and with FORE+OSEM for PET
  243. Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria
  244. Combined PET/CT Imaging in Oncology Impact on Patient Management
  245. Image Analysis in Patients with Cancer Studied with a Combined PET and CT Scanner
  246. PET Measures of Amphetamine-Induced Dopamine Release in Ventral versus Dorsal Striatum
  247. A Direct Comparison between Whole-Brain PET and BOLD fMRI Measurements of Single-Subject Activation Response
  248. Attenuation correction for a combined 3D PET/CT scanner
  249. Exact and approximate rebinning algorithms for 3-D PET data
  250. Statistical image reconstruction in PET with compensation for missing data
  251. A comparison of transform and iterative reconstruction techniques for a volume-imaging PET scanner with a large axial acceptance angle
  252. Basal Ganglia Studies with 3D Acquisition and 2D Reconstruction on a Retractable Septa PET Scanner
  253. The performance of the single-slice rebinning technique for imaging the human striatum as evaluated bp phantom studies
  254. Figures of merit for comparing reconstruction algorithms with a volume-imaging PET scanner
  255. Evaluation of task-oriented performance of several fully 3D PET reconstruction algorithms
  256. A methodology for testing for statistically significant differences between fully 3D PET reconstruction algorithms
  257. [11C]WAY 100635: A radioligand for imaging 5-HT1A receptors with positron emission tomography
  258. Effect of increased axial field of view on the performance of a volume PET scanner
  259. Positron emission tomography with a large axial acceptance angle: signal-to-noise considerations
  260. Position estimation and error correction in a 2D position-sensitive NaI(Tl) detector
  261. Toward the design of a positron volume imaging camera
  262. Analytic 3D image reconstruction using all detected events
  263. Three-dimensional image reconstruction in object space
  264. Conceptual design of a whole body PET machine
  265. The Theory of Three-Dimensional Image Reconstruction for PET
  266. A teachable neural network based on an unorthodox neuron
  267. The Effects of Object Size, Attenuation, Scatter, and Random Coincidences on Signal to Noise Ratio in Simulations of Time-of-Flight Positron Emission Tomography
  268. Simulation of Countrate Performance for a PET Scanner with Different Degrees of Partial Collimation
  269. Measured Spatially Variant System Response for PET Image Reconstruction
  270. A Quantitative Approach to a Weight-Based Scanning Protocol for PET Oncology Imaging
  271. Correction methods for random coincidences in 3D wholebody PET imaging
  272. The effect of attenuation on lesion detection in PET oncology
  273. Quantitative attenuation correction for PET/CT using iterative reconstruction of low-dose dual-energy CT